3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models
- 3 April 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (9) , 4606-4623
Abstract
Cyclin-dependent kinases are therapeutic targets frequently deregulated in various cancers. By convenient alkylation of the 5-sulfanyl group, we synthesized 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidines with various substitutions at position 5 with potent antiproliferative activity in non‐Hodgkin lymphoma cell lines. The most potent derivative 4.35 also displayed activities across more than sixty cancer cell lines. The kinase profiling confirmed high selectivity of 4.35 toward CDKs 2, 5 and 9, and the cocrystal with CDK2/cyclin A2 revealed its binding in the active site. Cultured lymphoma cell lines treated with 4.35 showed dephosphorylation of CDK substrates, cleavage of PARP-1, downregulation of XIAP and Mcl-1 and activation of caspases, which collectively confirmed ongoing apoptosis. Moreover, 4.35 demonstrated significant activity in various cell line xenograft and patient-derived xenograft mouse models in vivo both as a monotherapy and as a combination therapy with the BCL2-targeting venetoclax. These findings support further studies of combinatorial treatment based on CDK inhibitors.Keywords
Funding Information
- European Regional Development Fund (CZ.02.1.01/0.0/0.0/16_019/0000868)
- Grantov?? Agentura Cesk?? Republiky (17-14007S, P208/12/G016)
- Univerzita Palack??ho v Olomouci (IGA_PrF_2019_013)
- Univerzita Karlova v Praze (UNCE/MED/016, SVV 260265/2016)
This publication has 57 references indexed in Scilit:
- MCL1 is deregulated in subgroups of diffuse large B-cell lymphomaLeukemia, 2012
- Facilities for macromolecular crystallography at the Helmholtz-Zentrum BerlinJournal of Synchrotron Radiation, 2012
- Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative ActivityJournal of Medicinal Chemistry, 2011
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1Blood, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallographica Section D Structural Biology, 2009
- Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activityBlood, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994